Alcon AG | ALC - Net Income


Alcon AG reported $189M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AstraZeneca USD 2.51B 573M Jun/2026
Bayer EUR 219M 2.54B Jun/2026
Essilor EUR 1.57B 638M Jun/2026
Fresenius EUR 382M 53M Jun/2026
Fresenius Medical Care EUR 218.38M 100.38M Jun/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GRIFOLS EUR 154M 81M Jun/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 490M 169M Jun/2026
Novartis USD 3.26B 108M Jun/2026
Philips EUR 384M 233M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
Smith & Nephew USD 303M 10M Jun/2026
Sonova Holding CHF 188.5M 143.4M Dec/2025
UCB EUR 1.08B 608M Dec/2025